Skip to Content
Merck
  • In Situ Maturation and Tissue Adaptation of Type 2 Innate Lymphoid Cell Progenitors.

In Situ Maturation and Tissue Adaptation of Type 2 Innate Lymphoid Cell Progenitors.

Immunity (2020-10-02)
Patrice Zeis, Mi Lian, Xiying Fan, Josip S Herman, Daniela C Hernandez, Rebecca Gentek, Shlomo Elias, Cornelia Symowski, Konrad Knöpper, Nina Peltokangas, Christin Friedrich, Remi Doucet-Ladeveze, Agnieszka M Kabat, Richard M Locksley, David Voehringer, Marc Bajenoff, Alexander Y Rudensky, Chiara Romagnani, Dominic Grün, Georg Gasteiger
ABSTRACT

Innate lymphoid cells (ILCs) are generated early during ontogeny and persist predominantly as tissue-resident cells. Here, we examined how ILCs are maintained and renewed within tissues. We generated a single cell atlas of lung ILC2s and found that Il18r1+ ILCs comprise circulating and tissue-resident ILC progenitors (ILCP) and effector-cells with heterogeneous expression of the transcription factors Tcf7 and Zbtb16, and CD103. Our analyses revealed a continuous differentiation trajectory from Il18r1+ ST2- ILCPs to Il18r- ST2+ ILC2s, which was experimentally validated. Upon helminth infection, recruited and BM-derived cells generated the entire spectrum of ILC2s in parabiotic and shield chimeric mice, consistent with their potential role in the renewal of tissue ILC2s. Our findings identify local ILCPs and reveal ILCP in situ differentiation and tissue adaptation as a mechanism of ILC maintenance and phenotypic diversification. Local niches, rather than progenitor origin, or the developmental window during ontogeny, may dominantly imprint ILC phenotypes in adult tissues.

MATERIALS
Product Number
Brand
Product Description

Roche
Liberase TL Research Grade, lyophilized, suitable for tissue processing, optimum pH 7.4